The role of proton pump inhibitors in the treatment of Zollinger–Ellison syndrome

Bibliography

• ZOLLINGER RM, ELLISON EH: Primary peptic ulceration of the jejunum associated with islet cell tumors of the pancreas. Ann. Surg. (1955) 142(4):709-722.
   PubMed Web of Science ®Google Scholar
• ISENBERG JI, WALSH JH, GROSSMAN MI: Zollinger Ellison syndrome. Gastroenterology (1973) 65(1):140-165.
   PubMed Web of Science ®Google Scholar
• STAGE JG, STADIL F: The clinical diagnosis of the Zollinger-Ellison syndrome. Scand. J. Gastroenterol. (1979) 53:79-91.
   Google Scholar
• CORLETO VD, ANNIBALE B GIBRIL F et al.: Does the widespread use of proton pump inhibitors mask, complicate, and/or delay the diagnosis of Zollinger-Ellison syndrome? Aliment. Pharmacol. Ther. (2001) 15(10):1555-1561.
   PubMed Web of Science ®Google Scholar
• ZHUANG Z, VORTMEYER AO, PACK S et al.: Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res. (1997) 57(21):4682-4686.
   PubMed Web of Science ®Google Scholar
• YALOW RS, BERSON SA: Radioimmunoassay of gastrin. Gastroenterology (1970) 58(1):1-14.
   PubMed Web of Science ®Google Scholar
• HAVU N: Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion (1986) 35(1):42-55.
   PubMed Web of Science ®Google Scholar
• LI H, HELANDER HF: Hypergastrinemia increases proliferation of gastroduodenal epithelium during gastric ulcer healing in rats. Dig. Dis. Sci. (1996) 41(1):40-48.
   PubMed Web of Science ®Google Scholar
• SHIMODA SS, SAUNDERS DR, RUBIN CE: The Zollinger Ellison syndrome with steatorrhea. II. The mechanism of fat and vitamin B12 malabsorption. Gastroenterology (1968) 55(6):705-723.
   PubMed Web of Science ®Google Scholar
• HIRSCHOWITZ BI: Gastric secretion of acid and pepsin in patients with esophageal stricture and appropriate controls. Dig. Dis. Sci. (1996) 41(11):2115-2122.
   PubMed Web of Science ®Google Scholar
• YU F, VENZON DJ, SERRANO J et al.: Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas. Cancer (1999) 85(7):1470-1483.
   PubMed Web of Science ®Google Scholar
• DEVENEY CW, DEVENEY KS, JAFFE BM et al.: Use of calcium and secretin in the diagnosis of gastrinoma. Ann. Int. Med. (1977) 87(6):680-686.
   PubMed Web of Science ®Google Scholar
• IMAMURA M, TAKAHASHI K: Use of selective arterial secretin injection test to guide surgery in patients with Zollinger-Ellison syndrome. World J. Surg. (1993) 17(4):433-438.
   PubMed Web of Science ®Google Scholar
• WADA M, KOMOTO L, DOI R et al.: Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma. World J. Surg. (2002) 26(10):1291-1296.
   PubMed Web of Science ®Google Scholar
• TERMANINI B, GIBRIL F, STEWART CA et al.: A prospective study of the effectiveness of low dose omeprazole as initial therapy in Zollinger-Ellison syndrome. Aliment. Pharmacol. Ther. (1996) 10(1):61-71.
   PubMed Web of Science ®Google Scholar
• STEWART CA TERMANINI B, SUTLIFF VE et al.: Management of the Zollinger-Ellison syndrome in pregnancy. Am. J. Obstet. Gynecol. (1997) 176(1):224-233.
   PubMed Web of Science ®Google Scholar
• LEW EA, PISEGNA JR, STARR JA et al.: Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Gastroenterology (2000) 118(4):696-704.
   PubMed Web of Science ®Google Scholar
• RICHARDSON CT, WALSH JH: The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome. N. Engl. J. Med. (1976) 294(3):133-135.
   PubMed Web of Science ®Google Scholar
• ROY PK, VENZON DJ, FEIGENBAUM KM et al.: Gastric acid secretion in Zollinger-Ellison syndrome: correlation with clinical expression, tumor extent, and role in diagnosis- a prospective NIH study of 235 patients and a review of 984 cases in the literature. Medicine (2001) 80(3):189-222.
   PubMed Web of Science ®Google Scholar
• WILSON SD, ELLISON EH: Survival in patients with the Zollinger-Ellison syndrome treated by total gastrectomy. Am. J. Surg. (1966) 111(6):787-791.
   PubMed Web of Science ®Google Scholar
• STRADER DB, BENJAMIN SB, ORBUCH M et al.: Esophageal function and occurrence of Barrett’s esophagus in Zollinger-Ellison syndrome. Digestion (1995) 56(5):347-356.
   PubMed Web of Science ®Google Scholar
• CARSWELL CI, GOA KL: Rabeprazole: an update of its use in acid-related disorders. Drugs (2001) 61(15):2327-2356.
   PubMed Web of Science ®Google Scholar
• METZ DC, SOFFER E, FORSMARK CE et al.: Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion. Am. J. Gastroenterol. (2003) 98(2):301-307.
   PubMed Web of Science ®Google Scholar
• METZ DC, PISEGNA JR, RINGHAM GL et al.: Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome. Dig. Dis. Sci. (1993) 38(2):245-256.
   PubMed Web of Science ®Google Scholar
• HIRSCHOWITZ BI, SIMMONS J, MOHNEN J: Clinical outcome using lansoprazole in acid hypersecretors with nd without Zollinger-Ellison syndrome: a 13-year prospective study. Clin. Gastroenterol. Hepatol. (2005) 3(1):39-48.
   PubMed Web of Science ®Google Scholar
• KOVACS TO, LEE CQ, CHIU YL et al.: Intravenous and oral lansoprazole are equivalent in suppressing stimulated acid output in patient volunteers with erosive oesophagitis. Aliment. Pharmacol. Ther. (2004) 20(8):883-889.
   PubMed Web of Science ®Google Scholar
• CHEN CY, LU CL, LUO JC et al.: Esomeprazole tablet versus omeprazole capsule in treating erosive esophagitis. World J. Gastroenterol. (2005) 11(20):3112-3117.
   PubMed Web of Science ®Google Scholar
• METZ DC, PISEGNA JR, FISHBEYN VA et al.: Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high. Gastroenterology (1992) 103(5):1498-1508.
   PubMed Web of Science ®Google Scholar
• HOWARD JM, CHREMOS AN et al.: Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome. Gastroenterology (1985) 88(4):1026-1033.
   PubMed Web of Science ®Google Scholar
• COLLEN MJ, HOWARD JM, MCARTHUR KE et al.: Comparison of the effectiveness of ranitidine and cimetidine in the treatment of gastric hypersecretion. Ann. Int. Med. (1984) 100(1):52-58.
   PubMed Web of Science ®Google Scholar
• TAKEUCHI K, KAJIMURA M, KODAIRA M et al.: Up-regulation of H2 receptor and adenylate cyclase in rabbit parietal cells during prolonged treatment with H2-receptor antagonists. Dig. Dis. Sci. (1999) 44(8):1703-1709.
   PubMed Web of Science ®Google Scholar
• DANIELS IR: Omeprazole, its isomers, and the carcinoid question. Lancet (2001) 357(9264):1290-1291.
   PubMedGoogle Scholar
• SUZUKI H, HIBI T: Novel effects other than antisecretory action and off-label use of proton pump inhibitors. Expert Opin. Pharmacother. (2005) 6(1):59-67.
   PubMed Web of Science ®Google Scholar
• FISHBEYN VA, NORTON JA, BENYA RV et al.: Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach. Ann. Intern. Med. (1993) 119:199-206.
   PubMed Web of Science ®Google Scholar